ATE415486T1 - Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese - Google Patents

Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese

Info

Publication number
ATE415486T1
ATE415486T1 AT03749756T AT03749756T ATE415486T1 AT E415486 T1 ATE415486 T1 AT E415486T1 AT 03749756 T AT03749756 T AT 03749756T AT 03749756 T AT03749756 T AT 03749756T AT E415486 T1 ATE415486 T1 AT E415486T1
Authority
AT
Austria
Prior art keywords
artherogenesis
vivo
index
reverse transport
measuring speeds
Prior art date
Application number
AT03749756T
Other languages
English (en)
Inventor
Marc Hellerstein
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE415486T1 publication Critical patent/ATE415486T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1224—Lipoprotein vesicles, e.g. HDL and LDL proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT03749756T 2002-09-13 2003-09-15 Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese ATE415486T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41035202P 2002-09-13 2002-09-13

Publications (1)

Publication Number Publication Date
ATE415486T1 true ATE415486T1 (de) 2008-12-15

Family

ID=31994119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03749756T ATE415486T1 (de) 2002-09-13 2003-09-15 Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese

Country Status (10)

Country Link
US (2) US7255850B2 (de)
EP (1) EP1546373B1 (de)
JP (1) JP4610337B2 (de)
AT (1) ATE415486T1 (de)
AU (1) AU2003267283B2 (de)
CA (1) CA2498378C (de)
DE (1) DE60324950D1 (de)
DK (1) DK1546373T3 (de)
SG (1) SG149699A1 (de)
WO (1) WO2004025270A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910403A (en) 1997-05-15 1999-06-08 The Regents Of University Of California Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
ATE502578T1 (de) * 2001-10-24 2011-04-15 Univ California Messung der protein-syntheseraten bei menschen und in experimentellen systemen durch verwendung von isotopisch markiertem wasser
AU2003217385B2 (en) * 2002-02-12 2008-09-11 The Regents Of The University Of California Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
EP1546364A4 (de) 2002-07-30 2006-09-06 Univ California Verfahren zur automatischen messung im grossmassstab der molekularen flussgeschwindigkeiten des proteoms oder des organoms mittels massenspektrometrie
DE20211783U1 (de) * 2002-07-31 2002-11-07 Fa. Hermann Heye i.Ins., 31683 Obernkirchen Pressstempelmechanismus einer Glasformmaschine
US20060105339A1 (en) * 2002-09-04 2006-05-18 Marc Hellerstein Methods for measuring the rates of replication and death of microbial infectious agents in an infected
CA2498378C (en) * 2002-09-13 2013-12-17 The Regents Of The University Of California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
US20070248540A1 (en) * 2002-09-16 2007-10-25 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
WO2004042360A2 (en) 2002-11-04 2004-05-21 The Regents Of The Univeristy Of California Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
US7262020B2 (en) 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
WO2005094327A2 (en) * 2004-03-29 2005-10-13 The Regents Of The University Of California Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
WO2009158328A1 (en) * 2008-06-23 2009-12-30 Trustees Of The University Of Pennsylvania Method for in vivo measurement of reverse cholesterol transport
WO2011009035A1 (en) * 2009-07-16 2011-01-20 Trustees Of The University Of Pennsylvania Method for in vivo measurement of reverse cholesterol transport
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
WO2013086070A1 (en) 2011-12-07 2013-06-13 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
AU2016272252B2 (en) * 2015-05-29 2017-09-28 Sysmex Corporation Method for measuring cholesterol uptake capacity of lipoproteins and reagent kit thereof
WO2018073404A1 (en) * 2016-10-20 2018-04-26 Vito Nv Monoisotopic mass determination of macromolecules via mass spectrometry

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065552A (en) * 1975-05-05 1977-12-27 Giovanni Giacomo Costa Method of detecting malignant neoplasms
US4332784A (en) * 1979-02-06 1982-06-01 The Radiochemical Centre Limited Dual isotope assays
SU968036A1 (ru) 1980-03-10 1982-10-23 Научно-исследовательский институт медицинской радиологии АМН СССР Способ получени меченого белка
US5317098A (en) * 1986-03-17 1994-05-31 Hiroaki Shizuya Non-radioisotope tagging of fragments
DE3667103D1 (en) * 1986-06-09 1989-12-28 Bruker Analytische Messtechnik Method for determining the turnover of organic material in living tissue and nmr spectrometer for performing this method
US4940658A (en) * 1986-11-20 1990-07-10 University Patents, Inc. Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficency
WO1989001342A2 (en) * 1987-08-07 1989-02-23 Mallinckrodt, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5042488A (en) * 1987-09-29 1991-08-27 The Washington University Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ
US6004781A (en) 1988-01-22 1999-12-21 The General Hospital Corporation Nucleic acid encoding Ig-CD4 fusion proteins
EP0467885A4 (en) 1989-03-20 1993-03-31 Anticancer Inc. Native-state method and system for determining viability and proliferative capacity of tissues -i(in vitro)
US5026909A (en) 1989-03-22 1991-06-25 Zolotarev Jury A Method for preparing biologically active organic compound labelled with hydrogen isotope
US5217903A (en) * 1990-05-15 1993-06-08 Trustees Of Boston University Measuring connective tissue breakdown products in body fluids
US5209919A (en) * 1990-07-13 1993-05-11 Regents Of The University Of California Method of measurement in biological systems
CA2027714C (en) * 1990-07-13 2003-01-28 Kenneth W. Turtletaub Method of measurement in biological systems
US5597548A (en) * 1990-07-18 1997-01-28 Board Of Regents, The University Of Texas System 13 C Isotopomer analyses in intact tissue using (13 C) homonuclear decoupling
HU208084B (en) 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
US5394236A (en) * 1992-02-03 1995-02-28 Rutgers, The State University Methods and apparatus for isotopic analysis
WO1993020800A1 (en) * 1992-04-08 1993-10-28 Paavo Kai Johannes Kinnunen Composition for therapeutic or diagnostic use, process for its preparation and its use
US5338686A (en) * 1992-04-29 1994-08-16 Hellerstein Marc K Method for measuring in vivo synthesis of biopolymers
JP2960832B2 (ja) 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
US5366885A (en) 1992-06-09 1994-11-22 Barranco Iii Sam C Method and kit for testing tumors for drug sensitivity
US5506147A (en) * 1993-04-15 1996-04-09 Kolhouse; J. Fred Non-invasive evaluation of maldigestion and malaborption
US5665562A (en) 1993-05-17 1997-09-09 Amersham International Plc Devices and methods for the measurement of cellular biochemical processes
US5439803A (en) * 1993-08-13 1995-08-08 The Regents Of The University Of Michigan Isotope and assay for glycolysis and the pentose phosphate pathway
US5756067A (en) 1993-11-08 1998-05-26 Peptide Delivery Systems Pty Ltd Labelled diagnostic compositions and method of their use
US5664377A (en) * 1994-07-14 1997-09-09 Angelo; Arthur Apparatus and method to a ground surface foundation
EP0781145B1 (de) 1995-08-08 2003-07-16 Otsuka Pharmaceutical Co., Ltd. Diagnostische zusammensetzungen und deren anwendung in der diagnose von zentralnervösen anomalien
US5922554A (en) 1995-10-30 1999-07-13 The Regents Of The University Of California Inhibition of cellular uptake of cholesterol
US5925333A (en) * 1995-11-15 1999-07-20 Massachusetts Institute Of Technology Methods for modulation of lipid uptake
US5916538A (en) 1996-08-27 1999-06-29 Tokyo Gas Company Limited Diagnostic agent for diabetes
CA2281111A1 (en) 1997-02-14 1998-08-20 Fred P. Abramson An assay for the measurement of dna synthesis rates
AU745912B2 (en) 1997-03-14 2002-04-11 George Washington University, The A device for continuous isotope ratio monitoring following fluorine based chemical reactions
US5910403A (en) * 1997-05-15 1999-06-08 The Regents Of University Of California Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
US5961470A (en) * 1997-07-09 1999-10-05 Wagner; David A. Breath test for assessing hepatic function
US6329208B1 (en) * 1997-07-16 2001-12-11 Board Of Regents, The University Of Texas System Methods for determining gluconeogenesis, anapleurosis and pyruvate recycling
CA2249173C (en) * 1997-10-06 2008-12-16 Tokyo Gas Co., Ltd. Diagnostic agent for liver function
US5924995A (en) 1997-11-10 1999-07-20 Meretek Diagnostics Non-invasive method for the functional assessment of infants and children with an inherited metabolic disorder
EP1075286A2 (de) * 1998-05-06 2001-02-14 Isotechnika, Inc. 13c glukose-atemtest zur diagnosis von diabetes
US6461870B2 (en) * 1998-05-06 2002-10-08 Isotechnika Inc. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
US6284219B1 (en) 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
US6625547B1 (en) * 1998-08-05 2003-09-23 Washington State University Research Foundation Relative rates of cytochrome p450 metabolism
DE19839491A1 (de) * 1998-08-29 2000-03-02 Hermann Heumann Verfahren zur Markierung von Biopolymeren mit Isotopen
AU5585599A (en) 1998-08-31 2000-03-21 University Of Washington Stable isotope metabolic labeling for analysis of biopolymers
US6693186B2 (en) 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
US6887712B1 (en) * 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
US20030119069A1 (en) 1999-04-20 2003-06-26 Target Discovery, Inc. Labeling of protein samples
US6764817B1 (en) * 1999-04-20 2004-07-20 Target Discovery, Inc. Methods for conducting metabolic analyses
CA2370749A1 (en) 1999-04-20 2000-10-26 Target Discovery, Inc. Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
US6391649B1 (en) 1999-05-04 2002-05-21 The Rockefeller University Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy
US7057168B2 (en) 1999-07-21 2006-06-06 Sionex Corporation Systems for differential ion mobility analysis
US6653090B1 (en) * 1999-11-05 2003-11-25 University Of Alberta Methods for measuring the metabolism of and screening for drugs in isolated hearts
JP2001211782A (ja) 2000-02-02 2001-08-07 Masa Yamamoto ｔｏｂ遺伝子欠損ノックアウト非ヒト哺乳動物
JP2003532117A (ja) 2000-04-13 2003-10-28 サーモ フィニガン リミテッド ライアビリティ カンパニー 並列質量分析によるプロテオミクス解析
EP1311858B1 (de) * 2000-05-05 2006-11-02 Purdue Research Foundation Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
AU2001261394A1 (en) 2000-05-18 2001-11-26 Metabolic Solutions, Inc. Reverse isotope dilution assay and lactose intolerance assay
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
US7048907B2 (en) 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
GB0106923D0 (en) * 2001-03-20 2001-05-09 Univ Dundee Liver function test
US7256047B2 (en) * 2001-05-01 2007-08-14 Board Of Regents, The University Of Texas System Measurement of gluconeogenesis and intermediary metabolism using stable isotopes
WO2003001881A2 (en) * 2001-06-26 2003-01-09 New York State Office Of Mental Health Cell-based high-throughput screening methods
US6835927B2 (en) 2001-10-15 2004-12-28 Surromed, Inc. Mass spectrometric quantification of chemical mixture components
ATE502578T1 (de) * 2001-10-24 2011-04-15 Univ California Messung der protein-syntheseraten bei menschen und in experimentellen systemen durch verwendung von isotopisch markiertem wasser
WO2003054549A2 (en) 2001-12-08 2003-07-03 Micromass Uk Limited Method of mass spectrometry
US7635841B2 (en) 2001-12-12 2009-12-22 Micromass Uk Limited Method of mass spectrometry
AU2003217385B2 (en) 2002-02-12 2008-09-11 The Regents Of The University Of California Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
US20030180800A1 (en) * 2002-03-22 2003-09-25 Lee Wai-Nang Paul Stable isotope based dynamic metabolic profiling of living organisms for characterization of metabolic diseases, drug testing and drug development
US20050281745A1 (en) 2002-03-22 2005-12-22 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Stable isotope based dynamic metabolic profiling of living organisms for characterization of metabolic diseases, drug testing and drug development
US20060100903A1 (en) 2002-03-22 2006-05-11 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Method of enhancing the efficiency of a pharmaceutical business
US20030180710A1 (en) * 2002-03-22 2003-09-25 Lee Wai-Nang Paul Method of enhancing the efficiency of a pharmaceutical business
CA2503681A1 (en) 2002-04-05 2003-10-23 Marc K. Hellerstein Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
US20030211036A1 (en) 2002-05-07 2003-11-13 Hadassa Degani Method and apparatus for monitoring and quantitatively evaluating tumor perfusion
US7510880B2 (en) 2002-06-26 2009-03-31 Gross Richard W Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts
AU2003253702A1 (en) 2002-06-26 2004-01-19 The Regents Of The University Of California Methods and kits for determining energy expenditure in living organisms by metabolic water production
EP1546364A4 (de) 2002-07-30 2006-09-06 Univ California Verfahren zur automatischen messung im grossmassstab der molekularen flussgeschwindigkeiten des proteoms oder des organoms mittels massenspektrometrie
WO2004016156A2 (en) 2002-08-16 2004-02-26 The Regents Of The University Of California Dynamic hepatic recycling glucose tolerance test
US20060105339A1 (en) 2002-09-04 2006-05-18 Marc Hellerstein Methods for measuring the rates of replication and death of microbial infectious agents in an infected
CA2498378C (en) 2002-09-13 2013-12-17 The Regents Of The University Of California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
SG152923A1 (en) * 2002-09-16 2009-06-29 Univ California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
US20070248540A1 (en) 2002-09-16 2007-10-25 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
CA2800040C (en) 2002-10-29 2015-12-29 Target Discovery, Inc. Method for increasing ionization efficiency in mass spectroscopy
WO2004042360A2 (en) 2002-11-04 2004-05-21 The Regents Of The Univeristy Of California Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
US20040121305A1 (en) 2002-12-18 2004-06-24 Wiegand Roger Charles Generation of efficacy, toxicity and disease signatures and methods of use thereof
JP2006522340A (ja) 2003-04-02 2006-09-28 メルク　エンド　カムパニー　インコーポレーテッド 質量分析データの分析法
US20050014181A1 (en) 2003-06-18 2005-01-20 Galis Zorina S. Methods and compositions for the assessment of polymer assembly
EP1644856A2 (de) 2003-06-30 2006-04-12 Ajinomoto Co., Inc. Analyseverfahren für den intrazellulären metabolischen fluss durch verwendung eines mit isotop gekennzeichneten substrats
US7262020B2 (en) 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
WO2005009597A2 (en) 2003-07-03 2005-02-03 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
US20050202406A1 (en) 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
US8510054B2 (en) 2004-02-05 2013-08-13 Ajinomoto Co., Inc. Intracellular metabolic flux analysis method using substrate labeled with isotope
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
CA2559095A1 (en) 2004-03-11 2005-09-22 The Regents Of The University Of California Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
WO2005094327A2 (en) 2004-03-29 2005-10-13 The Regents Of The University Of California Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
US20050255509A1 (en) 2004-03-30 2005-11-17 Kinemed, Inc. In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes
JP4654592B2 (ja) 2004-04-02 2011-03-23 味の素株式会社 代謝フラックスの決定方法
US20060120961A1 (en) 2004-10-29 2006-06-08 Target Discovery, Inc. Glycan analysis using deuterated glucose
WO2006081521A2 (en) 2005-01-26 2006-08-03 The Regents Of The University Of Colorado Methods for diagnosis and intervention of hepatic disorders
CN101374555B (zh) 2005-04-06 2013-04-17 圣路易斯华盛顿州立大学 神经衍生的生物分子体内代谢的检测方法
US20060251576A1 (en) 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development

Also Published As

Publication number Publication date
HK1079822A1 (en) 2006-04-13
US8021644B2 (en) 2011-09-20
US7255850B2 (en) 2007-08-14
WO2004025270A2 (en) 2004-03-25
EP1546373A4 (de) 2005-09-28
EP1546373A2 (de) 2005-06-29
AU2003267283A1 (en) 2004-04-30
SG149699A1 (en) 2009-02-27
CA2498378A1 (en) 2004-03-25
JP2005539226A (ja) 2005-12-22
US20050249664A1 (en) 2005-11-10
AU2003267283B2 (en) 2009-09-03
EP1546373B1 (de) 2008-11-26
CA2498378C (en) 2013-12-17
DE60324950D1 (de) 2009-01-08
DK1546373T3 (da) 2009-03-30
WO2004025270A3 (en) 2005-03-24
JP4610337B2 (ja) 2011-01-12
US20080003179A1 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
ATE415486T1 (de) Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
NZ586737A (en) Compositions and methods of detecting tiabs
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
WO2005005977A3 (en) Fluorescent phospholipase assays and compositions
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
EP3851856A3 (de) Verfahren, array und verwendung davon
DE602004021281D1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
WO2004055491A3 (en) Novel method for sequence determination using nmr
DE60336217D1 (de) Verfahren zur bestimmung von enzym aktivität
ATE350659T1 (de) Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
FI20040255A7 (fi) Menetelmä pre-eklampsian riskin havaitsemiseksi
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2009125936A3 (ko) 다낭성 난소 증후군 진단을 위한 분석방법 및 키트
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
MX2007009547A (es) Metodo de deteccion de fiebre porcina clasica.
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
ATE527795T1 (de) Verfahren und system zur schätzung eines symbolzeitfehlers in einem breitband- übertragungssystem
ATE288587T1 (de) Verfahren zur bestimmung der lipid-aufnahme
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
WO2009126889A8 (en) Assays for detecting pregnancy-associated glycoproteins
ATE528651T1 (de) Diagnoseverfahren für pulmonale arterielle hypertonie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1546373

Country of ref document: EP